tiprankstipranks
Trending News
More News >
Venky's (India) Limited (IN:VENKEYS)
:VENKEYS
India Market

Venky's (India) Limited (VENKEYS) AI Stock Analysis

Compare
1 Followers

Top Page

IN:VENKEYS

Venky's (India) Limited

(VENKEYS)

Select Model
Select Model
Select Model
Neutral 54 (OpenAI - 5.2)
Rating:54Neutral
Price Target:
₹1,314.00
▼(-16.74% Downside)
Action:ReiteratedDate:12/11/25
Venky's (India) Limited's overall stock score is driven by a stable financial position with low debt and strong equity. However, technical indicators suggest bearish momentum, and the high P/E ratio indicates overvaluation, which are significant concerns for potential investors.
Positive Factors
Low Leverage / Strong Equity
Very low leverage and a high equity ratio provide durable financial stability and flexibility. This capital structure reduces refinancing risk during industry cycles, supports investment or loss absorption, and underpins long-term solvency and strategic optionality.
Vertical Integration / Diversified Revenue
Integrated operations across breeding, farming, processing and animal-health create multiple, related revenue streams and control over supply. Vertical scope supports margin protection, cross-selling, and resilience to single-segment shocks over the medium term.
Improved Margins and Net Income Growth
Higher gross margin and a return to positive net income reflect lasting progress on cost controls and product mix. Sustained margin improvement supports reinvestment capacity and profitability resilience even if top-line growth is moderate.
Negative Factors
Weak Free Cash Flow
A sharp decline in free cash flow and low FCF-to-net-income ratio constrain the company’s ability to self-fund capex, pay dividends, or reduce debt. Structural FCF weakness can limit strategic investment and heighten sensitivity to earnings volatility.
Revenue Decline & Low Operating Margins
Falling revenue combined with modest EBITDA margins points to underlying demand or pricing pressure and limited operational leverage. Persistently low operating profitability reduces buffer for cost shocks and limits sustainable free cash generation.
Exposure to Feed Costs and Disease Cyclicality
The business remains structurally exposed to volatile feed prices and biosecurity/disease risk. These external factors can produce multi-month revenue and margin swings, complicating forecasting and necessitating ongoing investment in risk mitigation.

Venky's (India) Limited (VENKEYS) vs. iShares MSCI India ETF (INDA)

Venky's (India) Limited Business Overview & Revenue Model

Company DescriptionVenky's (India) Limited engages in the production and sale of poultry products in India. It operates through three segments: Poultry and Poultry Products, Animal Health Products, and Oilseed. The Poultry and Poultry Products segment produces and sells day old broiler and layer chicks, specific pathogen free eggs, processed chicken products, poultry feeds, and other miscellaneous poultry products. The Animal Health Products segment produces and sells medicines and other health products for birds. The Oilseed segment produces and sells edible refined soya oil and soya de-oiled cake. It also operates a quick service restaurant under the Venky's XPRS name. The company was formerly known as Western Hatcheries Limited and changed its name to Venky's (India) Limited. The company was incorporated in 1976 and is based in Pune, India. Venky's (India) Limited is a subsidiary of Venkateshwara Hatcheries Private Limited.
How the Company Makes MoneyVENKEYS makes money primarily by selling poultry-related products and services across multiple integrated business lines. Key revenue streams typically include: (1) Poultry products and processing: revenue from the sale of chicken and poultry-based foods (including processed/frozen or value-added items where applicable) to retail consumers and to institutional buyers such as distributors, hotels, restaurants, and other food-service channels. Earnings in this segment are driven by volumes sold, product mix (fresh vs. value-added), and pricing linked to poultry market conditions. (2) Poultry breeding and commercial operations: revenue from supplying poultry breeding stock and/or day-old chicks to farmers and integrators, and from operating poultry farms; profitability depends on flock performance, hatchery output, and demand from the broader poultry farming ecosystem. (3) Animal health and nutrition: revenue from selling poultry and livestock health products (e.g., vaccines and therapeutics where applicable), feed additives, and supplements through veterinary and distribution channels; this stream benefits from recurring demand tied to farm health management and biosecurity requirements. (4) Other allied/ancillary income: if present in company reporting, this can include by-products and related poultry value-chain services. Across these streams, the company’s earnings are influenced by input costs (notably feed), poultry price cycles, disease/biosecurity conditions, distribution reach, and the degree of vertical integration that links breeding, farming, processing, and animal health.

Venky's (India) Limited Financial Statement Overview

Summary
Venky's (India) Limited shows a balanced financial position with strengths in its balance sheet, including low debt levels and strong equity. The income statement indicates profitability despite revenue challenges, while cash flow management needs improvement to ensure sustainable growth.
Income Statement
65
Positive
Venky's (India) Limited has shown a mixed performance in its income statement. Despite a decline in total revenue over the past year, the company has managed to improve its gross profit margin to 26.1% and net profit margin to 3.5%. The EBIT and EBITDA margins are relatively low at 17.3% and 5.2%, respectively, indicating challenges in operational efficiency. However, the net income has grown from the previous year, reflecting positive trends in cost management.
Balance Sheet
72
Positive
The balance sheet reflects a stable financial position with a debt-to-equity ratio of 0.11, indicating low leverage and conservative financing strategy. The return on equity stands at 7.9%, which is modest but shows profitability. The equity ratio is strong at 71.2%, suggesting a high proportion of assets financed by equity, providing financial stability. Overall, the balance sheet indicates a well-managed capital structure with low financial risk.
Cash Flow
60
Neutral
The cash flow statement shows a decline in free cash flow over the past year, with a negative free cash flow growth rate of -35.2%. The operating cash flow to net income ratio is 0.57, suggesting moderate cash generation efficiency. The free cash flow to net income ratio is 0.18, indicating limited cash flow available for reinvestment and dividends. While cash flow management shows some weaknesses, the company maintains positive operating cash flow.
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue33.65B33.07B37.38B42.34B44.00B31.17B
Gross Profit7.10B8.64B2.41B7.48B7.24B8.10B
EBITDA1.37B1.72B1.63B1.49B2.81B4.22B
Net Income572.70M1.17B790.68M704.80M1.65B2.68B
Balance Sheet
Total Assets0.0020.70B20.94B20.15B19.47B17.90B
Cash, Cash Equivalents and Short-Term Investments3.10B3.10B2.01B2.74B739.26M970.63M
Total Debt0.001.70B1.72B1.91B1.99B1.86B
Total Liabilities-14.76B5.95B7.24B7.16B6.98B6.85B
Stockholders Equity14.76B14.76B13.70B12.99B12.49B11.04B
Cash Flow
Free Cash Flow0.00205.00M316.13M438.30M-250.42M2.06B
Operating Cash Flow0.00663.30M819.73M861.10M50.28M2.42B
Investing Cash Flow0.00-382.70M-366.25M-265.50M-186.53M-459.44M
Financing Cash Flow0.00-301.40M-468.71M-450.30M-338.75M-1.48B

Venky's (India) Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price1578.15
Price Trends
50DMA
1466.86
Negative
100DMA
1439.80
Negative
200DMA
1487.61
Negative
Market Momentum
MACD
-53.91
Positive
RSI
37.49
Neutral
STOCH
22.90
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:VENKEYS, the sentiment is Negative. The current price of 1578.15 is above the 20-day moving average (MA) of 1370.08, above the 50-day MA of 1466.86, and above the 200-day MA of 1487.61, indicating a bearish trend. The MACD of -53.91 indicates Positive momentum. The RSI at 37.49 is Neutral, neither overbought nor oversold. The STOCH value of 22.90 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:VENKEYS.

Venky's (India) Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
65
Neutral
₹8.13B9.320.36%12.43%29.17%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
62
Neutral
₹15.63B120.130.06%
58
Neutral
₹7.12B43.5323.11%1930.97%
54
Neutral
₹18.15B11.000.69%-1.16%-78.82%
54
Neutral
₹4.17B296.890.43%11.46%-0.46%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:VENKEYS
Venky's (India) Limited
1,288.35
-300.52
-18.91%
IN:FOODSIN
Foods & Inns Ltd.
56.72
-28.92
-33.77%
IN:IFBAGRO
IFB Agro Industries Ltd.
760.10
317.00
71.54%
IN:PASHUPATI
Pashupati Cotspin Ltd.
990.00
487.51
97.02%
IN:SKMEGGPROD
SKM Egg Products Export (India) Ltd.
154.45
73.08
89.80%

Venky's (India) Limited Corporate Events

Venky’s (India) Reports Profitable Q3 and Nine-Month FY2025 Results
Feb 9, 2026

Venky’s (India) Limited reported its audited financial results for the quarter and nine months ended 31 December 2025, approved by the board on 9 February 2026 after review by the audit committee. The company posted quarterly revenue from operations of Rs 95,015 lakh and total income of Rs 96,998 lakh, with total expenses of Rs 90,384 lakh leading to a profit before tax of Rs 6,614 lakh and profit for the period of Rs 4,858 lakh.

On a nine‑month basis, revenue from operations reached Rs 2,62,685 lakh and total income Rs 2,65,871 lakh, against total expenses of Rs 2,60,590 lakh, resulting in profit before tax of Rs 5,281 lakh and profit for the period of Rs 1,788 lakh. Earnings per share for the nine months stood at Rs 26.89, indicating a profitable period and underscoring the company’s ability to maintain margins despite cost pressures in materials and other operating expenses.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 11, 2025